Anuh Pharma Limited Faces Tax Demand Order from Income Tax Department
Anuh Pharma Limited has received a tax demand and penalty order from the Income Tax Department concerning its Scrutiny Assessment for Assessment Year 2020-21. The order, which was received on June 18, 2026, relates to disallowances of certain deductions claimed under various provisions of the Income Tax Act, leading to a significant financial impact.The assessment resulted in a Penalty Order under section 270A from the Income Tax Department, Assessment Unit. The total quantifiable monetary impact on the company stands at Rs. 17,46,026/-, which includes the penalty specified under section 270A(9) read with section 270A(8) of the Income Tax Act.
Key details regarding the tax matter are as follows:
| Particulars | Details |
|---|---|
| Name of the Authority | Income Tax Department, Assessment Unit |
| Nature and Details of the action taken or order passed | Penalty Order under section 270A |
| Date of receipt of direction or order | June 18, 2026 at IST 23:29 Hrs. |
| Violation(s) / contravention(s) committed or alleged to be committed | Disallowances of certain deductions claimed under various provisions of the Income Tax Act. |
| Impact on financial, operation or other activities of the listed entity | Rs. 17,46,026/- (including Penalty u/s 270A(9) r.w.s. 270A(8)) |
The company has stated that it possesses adequate factual and legal grounds to challenge the order through appeal before Higher Appellate Forums within the prescribed timelines. Anuh Pharma Limited emphasized that there is no impact on the financial operations or other activities of the Company.
ANUHPHR Stock Price Movement
Anuh Pharma Limited shares closed lower today, shedding 1.58% as the stock settled at ₹77.6 in the post-market session. The equity saw significant trading activity, with 60,966 shares changing hands during the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.